ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 172 filers reported holding ARRAY BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $879,000 | +106.8% | 18,964 | +8.9% | 0.04% | +100.0% |
| Q1 2019 | $425,000 | +75.6% | 17,421 | +2.5% | 0.02% | +53.8% |
| Q4 2018 | $242,000 | -6.2% | 16,999 | 0.0% | 0.01% | +8.3% |
| Q3 2018 | $258,000 | -9.5% | 16,999 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $285,000 | +1.1% | 16,999 | -1.5% | 0.01% | 0.0% |
| Q1 2018 | $282,000 | +27.6% | 17,253 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $221,000 | +51.4% | 17,253 | +13.9% | 0.01% | +42.9% |
| Q3 2017 | $146,000 | +15.0% | 15,148 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $127,000 | +0.8% | 15,148 | +7.2% | 0.01% | 0.0% |
| Q1 2017 | $126,000 | +1.6% | 14,136 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $124,000 | +69.9% | 14,136 | +29.9% | 0.01% | +50.0% |
| Q3 2016 | $73,000 | +87.2% | 10,886 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $39,000 | +21.9% | 10,886 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $32,000 | -30.4% | 10,886 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $46,000 | -8.0% | 10,886 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $50,000 | -35.9% | 10,886 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $78,000 | -14.3% | 10,886 | -11.6% | 0.01% | -16.7% |
| Q1 2015 | $91,000 | +85.7% | 12,315 | +19.3% | 0.01% | +100.0% |
| Q4 2014 | $49,000 | +32.4% | 10,324 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $37,000 | -21.3% | 10,324 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $47,000 | -4.1% | 10,324 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $49,000 | -5.8% | 10,324 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $52,000 | -18.8% | 10,324 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $64,000 | – | 10,324 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|